Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Two Japanese Universities Confirm Depression Drug Paxil Treats Neuropathic Pain

This article was originally published in PharmAsia News

Executive Summary

According to research conducted by psychosomatic medicine professor Kazunori Mine of Fukuoka University, and neuropharmacology professor Kazuhide Inoue of Kyushu University, the depression drug Paxil (paroxetine) was found to treat neuropathic pain, a continuous sharp pain even after direct pain-causing factors have been treated. In 2003, Inoue discovered protein P2×4, which relates to signaling and is found in spinal marrow microglial cells and causes the disease. Paroxetine is believed to constrain the mechanism of action of P2×4. Rats with neuropathic pain symptoms were observed to have drastically reduced pain following administration of Paxil. (Click for more-Japanese language

Latest Headlines
See All
UsernamePublicRestriction

Register

SC067719

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel